Biolase CEO Flynn steps down | Personnel Moves – April 13, 2018

Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has demonstrated over the last three years.  We are grateful for his contributions to product quality and for his steadfast dedication to Biolase.  We thank him for his continued support and wish him all the best in this new phase of his professional career. We are pleased to have John take on this interim role. Since joining Biolase, he has become an integral part of the team and has demonstrated his leadership skills by improving our cash position and securing a firm financial footing for Biolase,” board chair Dr. Jonathan Lord said in a prepared statement. Biolase also said that it asked Dr. Lord to lead its exploration of strategic alternatives including licensing, joint ventures, partnerships, mergers or other options, according to an SEC filing. The company said it will not comment further on the process until it believes “disclosure is appropriate.” “Biolase has been and continues to be the leader in all-tissue lasers in the U.S. and outside the U.S. – our award winning Waterlase platform has set the bar high in the dental field. The utility of lasers in dentistry continues to expand as evidenced by success i...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Biolase Conventus Orthopaedics Endotronix Inc. Frequency Therapeutics General Electric Henry Schein Inc. mckeonproducts nsfhealthsciencescertification Omnicell Inc. PerkinElmer Inc. personnel-moves Source Type: news